Your browser doesn't support javascript.
loading
Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populations.
Wilke, Michael H; Becker, Karsten; Kloss, Sebastian; Heimann, Sebastian M; Goldmann, Anton; Weber, Bertram; Pletz, Mathias W; Simon, Philipp; Petrik, Christian.
Afiliación
  • Wilke MH; inspiring.health, Munich, Germany.
  • Becker K; Institute of Medical Microbiology, University Hospital Muenster, Germany.
  • Kloss S; Pfizer Deutschland GmbH, Berlin, Germany.
  • Heimann SM; 1st Department of Internal Medicine, Center for Integrated Oncology CIO Cologne Bonn, German Centre for Infection Research, University Hospital of Cologne, Germany.
  • Goldmann A; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitaetsmedizin Berlin, Germany.
  • Weber B; Pfizer Deutschland GmbH, Berlin, Germany.
  • Pletz MW; Center for Infectious Diseases and Infection Control, University Hospital Jena, Germany.
  • Simon P; Department of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Germany.
  • Petrik C; Pfizer Pharma GmbH, Berlin, Germany.
GMS Infect Dis ; 5: Doc02, 2017.
Article en En | MEDLINE | ID: mdl-30671324
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Observational_studies Idioma: En Revista: GMS Infect Dis Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Observational_studies Idioma: En Revista: GMS Infect Dis Año: 2017 Tipo del documento: Article